查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508419

双相情感障碍治疗市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Bipolar Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 143 Pages | 商品交期: 2-10个工作天内

价格

双相情感障碍治疗市场 - 报告范围

TMR 关于全球双相情感障碍治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 2018-2034年期间的市场，考虑2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球双极性情感疾患治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解双相情感障碍治疗市场。

市场概况
2023年市场价值 51 亿美元
2034 年市场价值 92 亿美元
复合年增长率 5.4%

该报告深入探讨了全球双极性情感障碍治疗市场的竞争格局。全球双相情感障碍治疗市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球双相情感障碍治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依治疗类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依治疗类型，2020-2034
    • 药物治疗
    • 心理治疗
    • 电痉挛疗法 (ECT)
    • 经颅磁刺激 (TMS)
    • 其他（住院等）
  • 市场吸引力：按治疗类型分类

第 7 章：全球市场分析与预测：按药物类别

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依药品类别，2020-2034
    • 情绪稳定剂
    • 抗精神病药
    • 抗忧郁药
    • 抗焦虑药
    • 其他（抗惊厥药等）
  • 市场吸引力：按药品类别

第 8 章：全球市场分析与预测：依双极性情感疾患类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：以双极性情感疾患类型，2020-2034
    • I型双极性情感障碍
    • II型双极性情感障碍
    • 循环性障碍
    • 其他（特定和未特定的双向情绪障碍及相关疾病等）
  • 市场吸引力：按双极性情感障碍类型

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2034
    • 医院
    • 专科诊所
    • 心理健康中心
    • 门诊手术中心
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Otsuka Pharmaceutical Co., Ltd.
    • AstraZeneca plc
    • GSK plc
    • Pfizer Inc.
    • Eli Lilly and Company
    • Johnson & Johnson
    • AbbVie Inc.
    • Novartis AG
    • Allergan plc
    • Lundbeck A/S
Product Code: TMRGL20855

Bipolar Disorder Treatment Market - Scope of Report

TMR's report on the global bipolar disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bipolar disorder treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bipolar disorder treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bipolar disorder treatment market.

Market Snapshot
Market Value in 2023US$ 5.1 Bn
Market Value in 2034US$ 9.2 Bn
CAGR5.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bipolar disorder treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bipolar disorder treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bipolar disorder treatment market.

The report delves into the competitive landscape of the global bipolar disorder treatment market. Key players operating in the global bipolar disorder treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bipolar disorder treatment market profiled in this report.

Key Questions Answered in Global bipolar disorder treatment Market Report:

  • What is the sales/revenue generated by bipolar disorder treatment across all regions during the forecast period?
  • What are the opportunities in the global bipolar disorder treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Bipolar Disorder Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global bipolar disorder treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bipolar disorder treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bipolar disorder treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bipolar Disorder Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Bipolar Disorder Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Treatment

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type of Treatment, 2020-2034
    • 6.3.1. Pharmacotherapy
    • 6.3.2. Psychotherapy
    • 6.3.3. Electroconvulsive Therapy (ECT)
    • 6.3.4. Transcranial Magnetic Stimulation (TMS)
    • 6.3.5. Others (Hospitalization, etc.)
  • 6.4. Market Attractiveness, by Type of Treatment

7. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Drug Class

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug Class, 2020-2034
    • 7.3.1. Mood Stabilizers
    • 7.3.2. Antipsychotics
    • 7.3.3. Anti-depressants
    • 7.3.4. Antianxiety Drugs
    • 7.3.5. Others (Anticonvulsants, etc.)
  • 7.4. Market Attractiveness, by Drug Class

8. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Bipolar Disorder

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 8.3.1. Bipolar I Disorder
    • 8.3.2. Bipolar II Disorder
    • 8.3.3. Cyclothymic Disorder
    • 8.3.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 8.4. Market Attractiveness, by Type of Bipolar Disorder

9. Global Bipolar Disorder Treatment Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Mental Health Centers
    • 9.3.4. Ambulatory Surgical Centers
  • 9.4. Market Attractiveness, by End-user

10. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Bipolar Disorder Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 11.2.1. Pharmacotherapy
    • 11.2.2. Psychotherapy
    • 11.2.3. Electroconvulsive Therapy (ECT)
    • 11.2.4. Transcranial Magnetic Stimulation (TMS)
    • 11.2.5. Others (Hospitalization, etc.)
  • 11.3. Market Attractiveness, by Type of Treatment
  • 11.4. Market Value Forecast, by Drug Class, 2020-2034
    • 11.4.1. Mood Stabilizers
    • 11.4.2. Antipsychotics
    • 11.4.3. Anti-depressants
    • 11.4.4. Antianxiety Drugs
    • 11.4.5. Others (Anticonvulsants, etc.)
  • 11.5. Market Attractiveness, by Drug Class
  • 11.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 11.6.1. Bipolar I Disorder
    • 11.6.2. Bipolar II Disorder
    • 11.6.3. Cyclothymic Disorder
    • 11.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 11.7. Market Attractiveness, by Type of Bipolar Disorder
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals
    • 11.8.2. Specialty Clinics
    • 11.8.3. Mental Health Centers
    • 11.8.4. Ambulatory Surgical Centers
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Type of Treatment
    • 11.11.2. By Drug Class
    • 11.11.3. By Type of Bipolar Disorder
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Bipolar Disorder Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 12.2.1. Pharmacotherapy
    • 12.2.2. Psychotherapy
    • 12.2.3. Electroconvulsive Therapy (ECT)
    • 12.2.4. Transcranial Magnetic Stimulation (TMS)
    • 12.2.5. Others (Hospitalization, etc.)
  • 12.3. Market Attractiveness, by Type of Treatment
  • 12.4. Market Value Forecast, by Drug Class, 2020-2034
    • 12.4.1. Mood Stabilizers
    • 12.4.2. Antipsychotics
    • 12.4.3. Anti-depressants
    • 12.4.4. Antianxiety Drugs
    • 12.4.5. Others (Anticonvulsants, etc.)
  • 12.5. Market Attractiveness, by Drug Class
  • 12.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 12.6.1. Bipolar I Disorder
    • 12.6.2. Bipolar II Disorder
    • 12.6.3. Cyclothymic Disorder
    • 12.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 12.7. Market Attractiveness, by Type of Bipolar Disorder
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals
    • 12.8.2. Specialty Clinics
    • 12.8.3. Mental Health Centers
    • 12.8.4. Ambulatory Surgical Centers
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Type of Treatment
    • 12.11.2. By Drug Class
    • 12.11.3. By Type of Bipolar Disorder
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Bipolar Disorder Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 13.2.1. Pharmacotherapy
    • 13.2.2. Psychotherapy
    • 13.2.3. Electroconvulsive Therapy (ECT)
    • 13.2.4. Transcranial Magnetic Stimulation (TMS)
    • 13.2.5. Others (Hospitalization, etc.)
  • 13.3. Market Attractiveness, by Type of Treatment
  • 13.4. Market Value Forecast, by Drug Class, 2020-2034
    • 13.4.1. Mood Stabilizers
    • 13.4.2. Antipsychotics
    • 13.4.3. Anti-depressants
    • 13.4.4. Antianxiety Drugs
    • 13.4.5. Others (Anticonvulsants, etc.)
  • 13.5. Market Attractiveness, by Drug Class
  • 13.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 13.6.1. Bipolar I Disorder
    • 13.6.2. Bipolar II Disorder
    • 13.6.3. Cyclothymic Disorder
    • 13.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 13.7. Market Attractiveness, by Type of Bipolar Disorder
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals
    • 13.8.2. Specialty Clinics
    • 13.8.3. Mental Health Centers
    • 13.8.4. Ambulatory Surgical Centers
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Type of Treatment
    • 13.11.2. By Drug Class
    • 13.11.3. By Type of Bipolar Disorder
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Bipolar Disorder Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 14.2.1. Pharmacotherapy
    • 14.2.2. Psychotherapy
    • 14.2.3. Electroconvulsive Therapy (ECT)
    • 14.2.4. Transcranial Magnetic Stimulation (TMS)
    • 14.2.5. Others (Hospitalization, etc.)
  • 14.3. Market Attractiveness, by Type of Treatment
  • 14.4. Market Value Forecast, by Drug Class, 2020-2034
    • 14.4.1. Mood Stabilizers
    • 14.4.2. Antipsychotics
    • 14.4.3. Anti-depressants
    • 14.4.4. Antianxiety Drugs
    • 14.4.5. Others (Anticonvulsants, etc.)
  • 14.5. Market Attractiveness, by Drug Class
  • 14.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 14.6.1. Bipolar I Disorder
    • 14.6.2. Bipolar II Disorder
    • 14.6.3. Cyclothymic Disorder
    • 14.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 14.7. Market Attractiveness, by Type of Bipolar Disorder
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals
    • 14.8.2. Specialty Clinics
    • 14.8.3. Mental Health Centers
    • 14.8.4. Ambulatory Surgical Centers
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Type of Treatment
    • 14.11.2. By Drug Class
    • 14.11.3. By Type of Bipolar Disorder
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Bipolar Disorder Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 15.2.1. Pharmacotherapy
    • 15.2.2. Psychotherapy
    • 15.2.3. Electroconvulsive Therapy (ECT)
    • 15.2.4. Transcranial Magnetic Stimulation (TMS)
    • 15.2.5. Others (Hospitalization, etc.)
  • 15.3. Market Attractiveness, by Type of Treatment
  • 15.4. Market Value Forecast, by Drug Class, 2020-2034
    • 15.4.1. Mood Stabilizers
    • 15.4.2. Antipsychotics
    • 15.4.3. Anti-depressants
    • 15.4.4. Antianxiety Drugs
    • 15.4.5. Others (Anticonvulsants, etc.)
  • 15.5. Market Attractiveness, by Drug Class
  • 15.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 15.6.1. Bipolar I Disorder
    • 15.6.2. Bipolar II Disorder
    • 15.6.3. Cyclothymic Disorder
    • 15.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 15.7. Market Attractiveness, by Type of Bipolar Disorder
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals
    • 15.8.2. Specialty Clinics
    • 15.8.3. Mental Health Centers
    • 15.8.4. Ambulatory Surgical Centers
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Type of Treatment
    • 15.11.2. By Drug Class
    • 15.11.3. By Type of Bipolar Disorder
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Otsuka Pharmaceutical Co., Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. AstraZeneca plc
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. GSK plc
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Pfizer Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Eli Lilly and Company
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Johnson & Johnson
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. AbbVie Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Novartis AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Allergan plc
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Lundbeck A/S
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 02: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 03: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 05: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 08: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 09: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 10: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 13: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 14: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 15: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 18: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 19: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 20: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 23: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 24: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 25: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 28: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 29: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 30: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Bipolar Disorder Treatment Market Size (US$ Bn), by Region, 2023 and 2034
  • Figure 02: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by Type of Treatment, 2023
  • Figure 03: Global Bipolar Disorder Treatment Market Value Share, by Type of Treatment, 2023
  • Figure 04: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by Drug Class, 2023
  • Figure 05: Global Bipolar Disorder Treatment Market Value Share, by Drug Class, 2023
  • Figure 06: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by Type of Bipolar Disorder, 2023
  • Figure 07: Global Bipolar Disorder Treatment Market Value Share, by Type of Bipolar Disorder, 2023
  • Figure 08: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by End-user, 2023
  • Figure 09: Global Bipolar Disorder Treatment Market Value Share, by End-user, 2023
  • Figure 10: Global Bipolar Disorder Treatment Market Value Share, by Region, 2023
  • Figure 11: Global Bipolar Disorder Treatment Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 12: Global Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 13: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 14: Global Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 15: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 16: Global Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 17: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 18: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by End-user, 2023
  • Figure 19: Global Bipolar Disorder Treatment Market Value Share, by End-user, 2023
  • Figure 20: Global Bipolar Disorder Treatment Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Bipolar Disorder Treatment Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 26: North America Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 27: North America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 28: North America Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 30: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 31: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 32: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 37: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 38: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 39: Europe Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 41: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 42: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 43: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 48: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 49: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 50: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 52: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 53: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 54: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 59: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 60: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 61: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 63: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 64: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 65: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 70: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 71: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 72: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 74: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 75: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 76: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034